Alzheimer Disease Clinical Trials in Krakow
2 recruitingKrakow, Poland
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 2
A Study of NTRX-07 in Participants With Alzheimer's Disease
Alzheimer DiseaseMild Cognitive Impairment
NeuroTherapia, Inc.48 enrolled6 locationsNCT07058688